[Federal Register Volume 59, Number 195 (Tuesday, October 11, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-25033]


[[Page Unknown]]

[Federal Register: October 11, 1994]


-----------------------------------------------------------------------


NUCLEAR REGULATORY COMMISSION
 

Advisory Committee on Medical Uses of Isotopes: Meeting Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene its next 
regular meeting of the Advisory Committee on Medical Uses of Isotopes 
(ACMUI) on November 17 and 18, 1994. Topics of discussion will include: 
(1) Rulemaking on ``Preparation, Transfer, and Use of Byproduct 
Material for Medical Use''; (2) status of implementation of the Quality 
Management rule; (3) progress report on the study of the medical use 
program by the National Academy of Science; (4) brachytherapy 
fractionation issues; (5) Abnormal Occurrence Criteria Revisions; (6) 
rulemaking on ``Release of Patients Containing Radiopharmaceuticals or 
Permanent Implants, 10 CFR 35.75''; (7) discussion on Advanced Notice 
of Proposed Rulemaking for 10 CFR Part 35; (8) issues involving 
misadministrations--follow up of patients, NRC use of consultants; (9) 
review and approval of the bylaws for the Committee; and (10) report on 
the Commission briefing held on October 20, 1994.

DATES: The meeting will being 8 a.m. on November 17 and 18, 1994.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
Room T2B3, 11545 Rockville Pike, Rockville, MD.

FOR FURTHER INFORMATION CONTACT:
Larry W. Camper, Office of Nuclear Material Safety and Safeguards, MS 
T8F5, U.S. Nuclear Regulatory Commission, Washington, DC 20555, 
Telephone 301-415-7269.

Conduct of the Meeting

    Barry Siegel, M.D. will chair the meeting. Dr. Siegel will conduct 
the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Larry W. Camper (address listed above). Comments 
must be received by November 10, 1994, in order to ensure consideration 
at the meeting. The transcript of the meeting will be kept open until 
November 28, 1994, for inclusion of written comments.
    2. Persons who wish to make oral statements should inform Mr. 
Camper, in writing, by November 3, 1994. Statements must pertain to the 
topics on the agenda for the meeting. The Chairman will rule on 
requests to make oral statements. Members of the public will be 
permitted to make oral statements if time permits. Permission to make 
oral statements will be based on the order in which requests are 
received. In general, oral statements will be limited to approximately 
5 minutes. Oral statements must be supplemented by detailed written 
statements, for the record. Rulings on who may speak, the order of 
presentation, and time allotments may be obtained by calling Mr. 
Camper, 301-415-7269, between 9 a.m. and 5 EST, on November 14, 1994.
    3. At the meeting, questions from attendees other than committee 
members, NRC consultants, and NRC staff will be permitted at the 
discretion of the Chairman.
    4. The transcript, minutes of the meeting, and written comments 
will be available for inspection, and copying, for a fee, at the NRC 
Public Document Room, 2120 L Street NW., Lower Level, Washington, DC 
20555, on or about December 9, 1994.
    5. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App.); and the Commission's regulations in 
Title 10, Code of Federal Regulations, Part 7.

    Dated: October 4, 1994.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 94-25033 Filed 10-7-94; 8:45 am]
BILLING CODE 7590-01-M